chr13:32914137:C>A Detail (hg19) (BRCA2)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr13:32,914,137-32,914,137 |
| hg38 | chr13:32,340,000-32,340,000 View the variant detail on this assembly version. |
HGVS
| Type | Transcript | Protein |
|---|---|---|
| RefSeq | NM_000059.3:c.5645C>A | NP_000050.2:p.Ser1882Ter |
| Ensemble | ENST00000544455.6:c.5645C>A | ENST00000544455.6:p.Ser1882Ter |
| ENST00000380152.8:c.5645C>A | ENST00000380152.8:p.Ser1882Ter |
Summary
MGeND
| Clinical significance |
|
| Variant entry | 24 |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
| JP | HGVD:[No Data.] |
| ToMMo:[No Data.] | |
| NCBN:[No Data.] | |
| NCBN(Hondo):[No Data.] | |
| NCBN(Ryukyu):[No Data.] | |
| East asia | ExAC:<0.001 |
Prediction
ClinVar
| Clinical Significance |
|
| Review star | ![]() |
| Show details | |
Disease area statistics
MGeND
| Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
|---|---|---|---|---|---|---|---|---|---|
|
|
2019/08/29 | breast, unspecified |
|
MGS000029
(TMGS000133) |
Hitoshi Nakagama | National Cancer Center Japan | |||
|
|
2019/08/29 | hereditary breast and ovarian cancer syndrome |
|
MGS000029
(TMGS000133) |
Hitoshi Nakagama | National Cancer Center Japan | |||
|
|
2018/01/13 | breast, unspecified |
|
MGS000028
(TMGS000049) |
Yukihide Momozawa | RIKEN |
30287823
|
||
|
|
2021/03/19 | control |
|
MGS000047
(TMGS000111) |
Yukihide Momozawa Koichi Matsuda |
RIKEN The University of Tokyo |
|||
|
|
2021/03/19 | breast |
|
MGS000048
(TMGS000112) |
Yukihide Momozawa Koichi Matsuda |
RIKEN The University of Tokyo |
|||
|
|
2021/03/19 | prostate |
|
MGS000049
(TMGS000113) |
Yukihide Momozawa Koichi Matsuda |
RIKEN The University of Tokyo |
|||
|
|
2021/03/19 | Colorectal |
|
MGS000050
(TMGS000114) |
Yukihide Momozawa Koichi Matsuda |
RIKEN The University of Tokyo |
|||
|
|
2021/03/19 | pancreatic |
|
MGS000051
(TMGS000115) |
Yukihide Momozawa Koichi Matsuda |
RIKEN The University of Tokyo |
|||
|
|
other |
|
MGS000001
(TMGS000137) |
Kenjiro Kosaki | Keio University | ||||
|
|
other |
|
MGS000067
(TMGS000139) |
Kenjiro Kosaki | Keio University | ||||
|
|
other |
|
MGS000001
(TMGS000154) |
Kenjiro Kosaki | Keio University | ||||
|
|
2020/04/20 | body of stomach |
|
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan | |||
|
|
2020/04/20 | stomach, unspecified |
|
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan | |||
|
|
2020/04/20 | head of pancreas |
|
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan | |||
|
|
2020/04/20 | bronchus or lung, unspecified |
|
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan |
ClinVar
| Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
|---|---|---|---|---|---|
|
|
2016-04-22 | reviewed by expert panel | Breast-ovarian cancer, familial, susceptibility to, 2 |
|
Detail |
|
|
2023-03-01 | criteria provided, multiple submitters, no conflicts | not provided |
|
Detail |
|
|
2024-01-16 | criteria provided, multiple submitters, no conflicts | Hereditary cancer-predisposing syndrome |
|
Detail |
|
|
2024-01-28 | criteria provided, multiple submitters, no conflicts | hereditary breast ovarian cancer syndrome |
|
Detail |
|
|
2015-11-01 | criteria provided, single submitter | Breast neoplasm |
|
Detail |
|
|
2023-10-16 | criteria provided, multiple submitters, no conflicts | Familial cancer of breast |
|
Detail |
|
|
2017-03-17 | criteria provided, single submitter | Breast and/or ovarian cancer |
|
Detail |
|
|
2018-12-01 | no assertion criteria provided | Neoplasm of ovary |
|
Detail |
|
|
2019-03-26 | criteria provided, single submitter | not specified |
|
Detail |
|
|
2020-04-15 | no assertion criteria provided | Malignant tumor of prostate,Metastatic Prostate Small Cell Carcinoma |
|
Detail |
|
|
2020-04-15 | no assertion criteria provided | Malignant tumor of prostate,Metastatic Prostate Small Cell Carcinoma |
|
Detail |
|
|
2021-12-10 | criteria provided, single submitter | breast carcinoma |
|
Detail |
|
|
2022-04-08 | criteria provided, single submitter | Glioma susceptibility 3,medulloblastoma,Malignant tumor of prostate,Familial cancer of breast,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Fanconi anemia complementation group D1 |
|
Detail |
|
|
2022-04-08 | criteria provided, single submitter | Glioma susceptibility 3,medulloblastoma,Malignant tumor of prostate,Familial cancer of breast,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Fanconi anemia complementation group D1 |
|
Detail |
|
|
2022-04-08 | criteria provided, single submitter | Glioma susceptibility 3,medulloblastoma,Malignant tumor of prostate,Familial cancer of breast,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Fanconi anemia complementation group D1 |
|
Detail |
|
|
2022-04-08 | criteria provided, single submitter | Glioma susceptibility 3,medulloblastoma,Malignant tumor of prostate,Familial cancer of breast,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Fanconi anemia complementation group D1 |
|
Detail |
|
|
2022-04-08 | criteria provided, single submitter | Glioma susceptibility 3,medulloblastoma,Malignant tumor of prostate,Familial cancer of breast,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Fanconi anemia complementation group D1 |
|
Detail |
|
|
2022-04-08 | criteria provided, single submitter | Glioma susceptibility 3,medulloblastoma,Malignant tumor of prostate,Familial cancer of breast,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Fanconi anemia complementation group D1 |
|
Detail |
|
|
2022-04-08 | criteria provided, single submitter | Glioma susceptibility 3,medulloblastoma,Malignant tumor of prostate,Familial cancer of breast,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Fanconi anemia complementation group D1 |
|
Detail |
|
|
2022-04-08 | criteria provided, single submitter | Glioma susceptibility 3,medulloblastoma,Malignant tumor of prostate,Familial cancer of breast,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Fanconi anemia complementation group D1 |
|
Detail |
|
|
2021-07-01 | no assertion criteria provided | Gastric cancer |
|
Detail |
|
|
no assertion provided | BRCA2-related disorder |
|
Detail |
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.240 | Breast-ovarian cancer, familial, susceptibility to, 2 | NA | CLINVAR | Detail | |
| 0.174 | Breast Cancer, Familial | NA | CLINVAR | Detail | |
| 0.391 | Hereditary Breast and Ovarian Cancer Syndrome | NA | CLINVAR | Detail | |
| 0.128 | Neoplastic Syndromes, Hereditary | NA | CLINVAR | Detail | |
| 0.120 | Glioma susceptibility 3 | NA | CLINVAR | Detail | |
| 0.241 | medulloblastoma | NA | CLINVAR | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Breast-ovarian cancer, familial, susceptibility to, ... | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND not provided | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Hereditary cancer-predisposing syndrome | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Hereditary breast ovarian cancer syndrome | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Breast neoplasm | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Familial cancer of breast | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Breast and/or ovarian cancer | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Neoplasm of ovary | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND not specified | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Breast carcinoma | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND Gastric cancer | ClinVar | Detail |
| NM_000059.4(BRCA2):c.5645C>A (p.Ser1882Ter) AND BRCA2-related disorder | ClinVar | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs80358785 dbSNP
- Genome
- hg19
- Position
- chr13:32,914,137-32,914,137
- Variant Type
- snv
- Reference Allele
- C
- Alternative Allele
- A
- East Asian Chromosome Counts (ExAC)
- 8628
- East Asian Allele Counts (ExAC)
- 1
- East Asian Heterozygous Counts (ExAC)
- 1
- East Asian Homozygous Counts (ExAC)
- 0
- East Asian Allele Frequency (ExAC)
- 1.159017153453871E-4
- Chromosome Counts in All Race (ExAC)
- 120628
- Allele Counts in All Race (ExAC)
- 3
- Heterozygous Counts in All Race (ExAC)
- 3
- Homozygous Counts in All Race (ExAC)
- 0
- Allele Frequency in All Race (ExAC)
- 2.4869847796531487E-5
Genome browser
